Health

New Findings from AAIC Indicated Brain-Gut Axis to be the New Breakthrough in the Research Field of Alzheimer's Disease

SHANGHAI, July 29, 2020 /PRNewswire/ -- Alzheimer's disease has been an unsolved puzzle for scientists since the first patient was found over 100 years ago. Different theories like cholinergic hypothesis, amyloid cascade hypothesis, and tau protein hypothesis have made progress in research but f...

2020-07-29 15:28 973

Viva Biotech and Schrödinger Announce Strategic Collaboration to Generate and Interrogate Structures for Unsolved Targets

SHANGHAI and NEWYORK, July 28, 2020 /PRNewswire/ -- Viva Biotech Holdings (1873.HK) and Schrödinger, Inc. (Nasdaq: SDGR) today announced a strategic collaboration to expand the reach of structure-based drug discovery by generatingde novo crystal structures of high-value targets. Under the terms ...

2020-07-29 07:00 9570

I-Mab Drives Commercialization Strategy with Appointment of Ivan Yifei Zhu as Chief Commercial Officer

SHANGHAI and GAITHERSBERG, Md., July 28, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced the appointment of Mr.Ivan Yifei Zhu as its Chief Commer...

2020-07-28 20:22 9115

Foresee Pharmaceuticals Announces Submission of NDA for FDA Approval of LMIS 50 mg

TAIPEI, Taiwan, July 27, 2020 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), announced today that it has submitted to the U.S. Food and Drug Administration a 505(b)(2) New Drug Application for Camcevi™ 42mg (FP-001 LMIS 50mg), a ready-to-use 6-month depot formulation of...

2020-07-28 12:34 1014

Mayne Pharma Launches Chlorzoxazone Tablet in the United States

ADELAIDE, Australia, July 27, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that the US Food and Drug Administration (FDA) has granted approval of its Abbreviated New Drug Application (ANDA) for chlorzoxazone tablet, 375 mg, 500 mg and 750 mg, inthe United Stat...

2020-07-28 12:02 6764

Sherpa Healthcare Partners Announces Close of Oversubscribed Fund

BEIJING, July 27, 2020 /PRNewswire/ -- Sherpa Healthcare Partners is pleased to announce the final closing of the oversubscribed Sherpa Healthcare Fund I, L.P. The fund focuses on early- to growth-stage investment in the healthcare sector to cover companies in biotech, biopharma, medical devices ...

2020-07-28 11:33 1180

K-BioMed Pioneer: VUNO Med®-Fundus AI™ Becomes Korea's First-ever Innovative Medical Device

SEOUL, South Korea, July 27, 2020 /PRNewswire/ -- VUNO Inc., South Korean artificial intelligence (AI) developer and a member company of theBorn2Global Centre, announced that VUNO Med®-Fundus AI™, its AI-based screening solution for the fundus, gained the honor of being the first-ever Innovative ...

2020-07-27 22:00 1396

111, Inc. Launched Lung Cancer Patient Care Program "Cloud Enabled Lung Cancer Care by Great Doctors" for Full Life-cycle Management of Tumor

SHANGHAI, July 27, 2020 /PRNewswire/ -- Aiming to provide better health management services to lung cancer patients, "Cloud Enabled Lung Cancer Care by Great Doctors" was officially launched inShanghai on July 25, 2020. The lung cancer patient care program (the "Program"), spearheaded by China...

2020-07-27 18:00 6685

Heroic-Faith raised US$ 4 million for COVID-19 Unprecedented Need of Remote Patient Monitoring

TAIPEI, Taiwan, July 25, 2020 /PRNewswire/ -- Heroic-Faith uses deep learning and other forms of AI to develop algorithms that assist in the identification of normal and adventitious lung sounds, such as inhalation, exhalation, wheeze, stridor and crackles. The technology is also able to respo...

2020-07-25 23:30 2765

Happiness Biotech Announces Financial Results for Fiscal Year Ended March 31, 2020

NANPING, China, July 24, 2020  /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, today announced its financial results for the fiscal year endedMarch 31, 2020. FY 2020 Financial Highlights: ...

2020-07-25 05:00 23511

Tourism Gradually Recovers in the Ancient Capital of Xi'an

XI'AN, China, July 24, 2020 /PRNewswire/ -- As China's epidemic continues to improve due to the effective domestic prevention and control measures, the tourism industry is gradually recovering in the ancient capital ofXi'an, after having been down for just over three months. OnJuly 19, the Xi'an ...

2020-07-24 17:18 1388

FUJIFILM Sonosite Launches New Point-Of-Care Ultrasound System With Adaptable Form Factor, Embedded Workflow, And The Most Advanced Image Clarity Sonosite Has Ever Offered

BROOKVALE, New South Wales, July 24, 2020 /PRNewswire/ -- FUJIFILM Sonosite, Inc., specialists in developing cutting-edge point-of-care ultrasound (POCUS) solutions, and part of the largerFujifilm Healthcare portfolio, has announced the launch of the new Sonosite PX ultrasound system. Sonosite PX...

2020-07-24 07:00 1929

Gracell Expands Executive Team by Appointment of CMO Dr. Martina Sersch and CFO Dr. Kevin Xie

SHANGHAI and SUZHOU, China, July 23, 2020 /PRNewswire/ -- Internationally renowned clinical-stage immune cell and gene therapy company, Gracell Biotechnologies Co., Ltd. ("Gracell" or "the Company") has announced two appointments to the executive suite. Chief Medical Officer Dr.Martina Sersch, M...

2020-07-23 22:00 1516

Clarity Pharmaceuticals opens SARTATE neuroblastoma clinical trial

SYDNEY, July 23, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has opened its trial of67Cu-SARTATE™ for paediatric patients with neuroblastoma at Memorial Sloan Kettering Cancer Center (MSK) ...

2020-07-23 21:13 1192

Singlera Genomics and Fudan University unveiled results demonstrating detection of five common cancers earlier than standard test

SAN DIEGO and SHANGHAI, July 21, 2020 /PRNewswire/ -- Fudan University's Taizhou Health Science Institute and Singlera Genomics, focused on non-invasive early cancer detection, today announce the publication of a peer reviewed manuscript demonstrating the initial results from the Taizhou Longitud...

2020-07-21 23:00 1118

COVID-19 Fibroblast Based Cell Therapy Candidate Shown to Reduce Lung Scarring in Aggressive Animal Model

FibroGenesis Advances Preclinical Data in Preparation for FDA Investigational New Drug Submission HOUSTON, July 21, 2020 /PRNewswire/ -- FibroGenesis announced today new data supporting use of its PneumoBlast™ product in the battle against COVID-19. Using the widely accepted bleomycin model of l...

2020-07-21 22:08 1384

Saint Luke's Health System signs with Clinch to accelerate and streamline hiring

NEW YORK, July 21, 2020 /PRNewswire/ -- Saint Luke's Health System has engaged Clinch , a PageUp company, to provide recruitment marketing solutions including a new career site for theirMissouri-based a...

2020-07-21 22:07 1084

GenScript launches CDMO segment "GenScript ProBio" at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum

SHANGHAI, July 21, 2020 /PRNewswire/ -- The inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum successfully concluded in Shanghai on July 17, at which more than 700 authoritative researchers and corporate leaders shared insights on the future growth of the cell and ...

2020-07-21 22:04 1154

Clarity Pharmaceuticals and ImaginAb to Collaborate on New Cancer Targets

SYDNEY and LOS ANGELES, July 21, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, and ImaginAb, Inc., a company that harnesses the specificity of monoclonal antibodies, have entered into a collaboration agreement to develop n...

2020-07-21 21:13 1194

Samsung Biologics Posts Strong Second Quarter Earnings With 48.5% Increase In Sales

INCHEON, South Korea, July 21, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced today strong financial results for its fiscal 2020 second quarter endingJune 30, 2020, maintaining steady business performance with a high operating margin at 26.4%.

2020-07-21 20:20 15464
12345 ... 568